Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,376
Total Claims
$1.4M
Drug Cost
298
Beneficiaries
$4,811
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+351%
Cost per patient vs peers
$4,811 vs $1,068 avg
+99%
Brand preference vs peers
17.9% vs 9.0% avg
Brand vs Generic
Brand: 2,189 claims · $1.1M
Generic: 10,050 claims · $310K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 133 | $92K |
| Sitagliptin Phosphate | 84 | $62K |
| Diclofenac Sodium | 18 | $52K |
| Linaclotide | 77 | $46K |
| Semaglutide | 43 | $43K |
| Diclofenac Sodium | 233 | $40K |
| Diclofenac Epolamine | 54 | $38K |
| Dapagliflozin Propanediol | 53 | $35K |
| Umeclidinium Bromide | 79 | $34K |
| Mirabegron | 64 | $34K |
| Budesonide/Formoterol Fumarate | 71 | $30K |
| Empagliflozin | 34 | $30K |
| Emtricitabine/Tenofov Alafenam | 12 | $28K |
| Linagliptin | 44 | $28K |
| Rivaroxaban | 40 | $27K |
Prescribing Profile
Patient Profile
71
Avg Age
59%
Female
1.46
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data